Stability of human salivary extracellular vesicles containing dipeptidyl peptidase IV under simulated gastrointestinal tract conditions

被引:12
|
作者
Ogawa, Yuko [1 ]
Akimoto, Yoshihiro [2 ]
Ikemoto, Mamoru [1 ]
Goto, Yoshikuni [1 ]
Ishikawa, Anna [1 ]
Ohta, Sakura [1 ]
Takase, Yumi [1 ]
Kawakami, Hayato [2 ]
Tsujimoto, Masafumi [1 ]
Yanoshita, Ryohei [1 ]
机构
[1] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan
[2] Kyorin Univ, Dept Anat, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan
关键词
Extracellular vesicles; Exosomes; Stability; Human whole saliva; Dipeptidyl peptidase IV; Gastrointestinal condition; EXOSOME-LIKE VESICLES; EPITHELIAL-CELLS; SERUM;
D O I
10.1016/j.bbrep.2021.101034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Extracellular vesicles (EVs) have been isolated from various sources, including primary and cultured cell lines and body fluids. Previous studies, including those conducted in our laboratory, have reported the stability of EVs under various storage conditions. Methods: EVs from human whole saliva were separated via size-exclusion chromatography. To simulate the effects of gastric or intestinal fluids on the stability of EVs, pepsin or pancreatin was added to the samples. Additionally, to determine the effect of bile acids, sodium cholate was added. The samples were then subjected to western blotting, dynamic light scattering, and transmission electron microscopy analyses. In addition, the activity of dipeptidyl peptidase (DPP) IV retained in the samples was examined to monitor the stability of EVs. Results: Under acidic conditions, with pepsin mimicking the milieu of the stomach, the EVs remained stable. However, they partially lost their membrane integrity in the presence of pancreatin and sodium cholate, indicating that they may be destabilized after passing through the duodenum. Although several associated proteins, such as mucin 5B and CD9 were degraded, DPP IV was stable, and its activity was retained under the simulated gastrointestinal conditions. Conclusion: Our data indicate that although EVs can pass through the stomach without undergoing significant damage, they may be disrupted in the intestine to release their contents. The consistent delivery of active components such as DPP IV from EVs into the intestine might play a role in the efficient modulation of homeostasis of the signal transduction pathways occurring in the gastrointestinal tract.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Exosome-like vesicles with dipeptidyl peptidase IV in human saliva
    Ogawa, Yuko
    Kanai-Azuma, Masami
    Akimoto, Yoshihiro
    Kawakami, Hayato
    Yanoshita, Ryohel
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1059 - 1062
  • [2] Placental extracellular vesicles express active dipeptidyl peptidase IV; levels are increased in gestational diabetes mellitus
    Kandzija, Neva
    Zhang, Wei
    Motta-Mejia, Carolina
    Mhlomi, Vuyane
    McGowan-Downey, Jennifer
    James, Tim
    Cerdeira, Ana Sofia
    Tannetta, Dionne
    Sargent, Ian
    Redman, Christopher W.
    Bastie, Claire C.
    Vatish, Manu
    JOURNAL OF EXTRACELLULAR VESICLES, 2019, 8 (01):
  • [3] DIPEPTIDYL-PEPTIDASE-IV, A MEMBRANE PROTEASE IN THE GASTROINTESTINAL-TRACT OF EXPERIMENTAL-ANIMALS AND HUMANS
    KREISEL, W
    LOFFL, S
    GEROK, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (09): : 608 - 608
  • [4] Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate: Influence of fractionation, stability to simulated gastrointestinal digestion and food-drug interaction
    Nongonierma, Alice B.
    FitzGerald, Richard J.
    INTERNATIONAL DAIRY JOURNAL, 2013, 32 (01) : 33 - 39
  • [5] Novel Dipeptidyl Peptidase IV Inhibitory and Antioxidant Peptides Derived from Human Gastrointestinal Endogenous Proteins
    Lakshmi A. Dave
    Maria Hayes
    Paul J. Moughan
    Shane M. Rutherfurd
    International Journal of Peptide Research and Therapeutics, 2016, 22 : 355 - 369
  • [6] Novel Dipeptidyl Peptidase IV Inhibitory and Antioxidant Peptides Derived from Human Gastrointestinal Endogenous Proteins
    Dave, Lakshmi A.
    Hayes, Maria
    Moughan, Paul J.
    Rutherfurd, Shane M.
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2016, 22 (03) : 355 - 369
  • [7] HYDROLYSIS AND TRANSPORT OF PROLINE-CONTAINING PEPTIDES IN RENAL BRUSH-BORDER MEMBRANE-VESICLES FROM DIPEPTIDYL PEPTIDASE-IV-POSITIVE AND DIPEPTIDYL PEPTIDASE-IV-NEGATIVE RAT STRAINS
    TIRUPPATHI, C
    MIYAMOTO, Y
    GANAPATHY, V
    ROESEL, RA
    WHITFORD, GM
    LEIBACH, FH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (03) : 1476 - 1483
  • [8] Solid lipid nanoparticles enhance the resistance of oat-derived peptides that inhibit dipeptidyl peptidase IV in simulated gastrointestinal fluids
    Su, Lijing
    Zhou, Fa
    Yu, Mengru
    Ge, Rui
    He, Jiatai
    Zhang, Bo
    Zhang, Yanyan
    Fan, Junfeng
    JOURNAL OF FUNCTIONAL FOODS, 2020, 65
  • [9] Identification and characterization of two novel dipeptidyl peptidase-IV inhibitory peptides from the simulated gastrointestinal digestion of Tartary buckwheat proteins
    Wu, Weijing
    Qiu, Ju
    Wang, Libo
    Tan, Qianglai
    Zhuang, Ziyuan
    Wang, Yanling
    Wu, Lanlan
    FOOD CHEMISTRY, 2025, 473
  • [10] The Expression of Glucagon-Like Peptide-1 Receptor and Dipeptidyl Peptidase-IV in Neuroendocrine Neoplasms of the Pancreas and Gastrointestinal Tract
    Wada, Ryuichi
    Yagihashi, Soroku
    ENDOCRINE PATHOLOGY, 2014, 25 (04) : 390 - 396